KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Location
100 Corporate Drive, Mahwah, New Jersey
State of incorporation
New York
Fiscal year end
December 31
Former names
REPRO MED SYSTEMS INC (to 6/3/2022)
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 477 % -4.48%
Quick Ratio 94.2 % -17.5%
Debt-to-equity 34 % +8.73%
Return On Equity -55.9 % -107%
Return On Assets -41.7 % -102%
Operating Margin -31.3 % +15.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +0.42%
Common Stock, Shares, Outstanding 45.7M shares +0.4%
Entity Public Float 111M USD +54.7%
Common Stock, Value, Issued 491K USD +0.37%
Weighted Average Number of Shares Outstanding, Basic 45.7M shares +0.49%
Weighted Average Number of Shares Outstanding, Diluted 45.7M shares +0.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 29.3M USD +0.96%
Research and Development Expense 5.65M USD +5.22%
Operating Income (Loss) -9.17M USD +14.3%
Nonoperating Income (Expense) 453K USD +148%
Income Tax Expense (Benefit) 3.97M USD
Net Income (Loss) Attributable to Parent -13.3M USD -55.4%
Earnings Per Share, Basic -0.29 USD/shares -61.1%
Earnings Per Share, Diluted -0.29 USD/shares -61.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.8M USD -11.5%
Accounts Receivable, after Allowance for Credit Loss, Current 4.39M USD +5.48%
Inventory, Net 3.15M USD -52.6%
Assets, Current 19.5M USD -22.7%
Deferred Income Tax Assets, Net 5.45M USD +54.7%
Property, Plant and Equipment, Net 3.76M USD -3.85%
Operating Lease, Right-of-Use Asset 3.43M USD -7.5%
Other Assets, Noncurrent 99K USD 0%
Assets 27.5M USD -28.1%
Accounts Payable, Current 1.77M USD +18%
Employee-related Liabilities, Current 519K USD +3.8%
Accrued Liabilities, Current 1.46M USD -8.31%
Liabilities, Current 4.85M USD +7.27%
Operating Lease, Liability, Noncurrent 3.24M USD -9.06%
Liabilities 8.38M USD -0.88%
Retained Earnings (Accumulated Deficit) -25.2M USD -111%
Stockholders' Equity Attributable to Parent 19.1M USD -35.8%
Liabilities and Equity 27.5M USD -28.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -347K USD +92.6%
Net Cash Provided by (Used in) Financing Activities -182K USD +23.8%
Net Cash Provided by (Used in) Investing Activities -133K USD +53.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 49.1M shares +0.37%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -662K USD +87.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.3K USD -0.24%
Deferred Tax Assets, Valuation Allowance 6.4M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 3.61M USD -7.66%
Depreciation 215K USD +8.96%
Lessee, Operating Lease, Liability, to be Paid 2.83M USD +2007%
Property, Plant and Equipment, Gross 6.69M USD +9.1%
Operating Lease, Liability, Current 372K USD +6.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 512K USD +2.51%
Lessee, Operating Lease, Liability, to be Paid, Year One 384K USD +2.51%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 512K USD +2.51%
Deferred Federal Income Tax Expense (Benefit) 2.04M USD +1.06%
Lessee, Operating Lease, Liability, to be Paid, Year Four 512K USD +2.51%
Operating Lease, Payments 120K USD +5.76%
Current State and Local Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 889K USD +28.6%
Deferred Tax Assets, Net of Valuation Allowance 3.97M USD +104%